Immune boost tested to help preemies breathe
NCT ID NCT06925360
Summary
This study is testing whether giving intravenous immunoglobulin (IVIG), a solution of antibodies, can help treat a serious lung condition called bronchopulmonary dysplasia in very premature babies. It will involve about 20 infants born between 25 and 30 weeks of pregnancy who show signs of the lung disease. The main goal is to see if the treatment helps babies survive without needing breathing support by 36 weeks of adjusted age.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
International Peace Maternity and Child Health Hospital
RECRUITINGShanghai, Shanghai Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.